Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Financial Officer sold 1,453 shares at $10.54 ($15,320)
  2. 4 Open-market sale Chief Scientific Officer sold 1,453 shares at $10.54 ($15,320)
  3. 4 Open-market sale President and CEO sold 797 shares at an average $10.43 ($8,313)
  4. 4 Open-market sale Chief Operating Officer sold 185 shares at an average $10.43 ($1,930)
  5. 4 Open-market sale Chief Scientific Officer sold 267 shares at an average $10.43 ($2,785)
  6. 4 Open-market sale Chief Financial Officer sold 267 shares at an average $10.43 ($2,785)
  7. 4 Insider Changes in Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Chief Medical Officer acquired 21,900 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 9 · 173 filings